Condensed Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	At the Market Offering	IPO	Common Stock	Common Stock At the Market Offering	Common Stock IPO	Additional Paid-In Capital	Additional Paid-In Capital At the Market Offering	Additional Paid-In Capital IPO	Accumulated Deficit
Balance at Dec. 31, 2023	$ 169,237			$ 4			$ 418,058			$ (248,825)
Balance (in shares) at Dec. 31, 2023				35,866,610
Issuance of restricted stock (in shares)				44,226
Exercise of stock options	116						116
Exercise of stock options, (in shares)				22,750
Stock-based compensation expense	5,022						5,022
Net Income (Loss)	(39,061)									(39,061)
Balance at Mar. 31, 2024	135,314			$ 4			423,196			(287,886)
Balance (in shares) at Mar. 31, 2024				35,933,586
Balance at Dec. 31, 2023	169,237			$ 4			418,058			(248,825)
Balance (in shares) at Dec. 31, 2023				35,866,610
Net Income (Loss)	(76,337)
Balance at Jun. 30, 2024	103,948			$ 4			429,106			(325,162)
Balance (in shares) at Jun. 30, 2024				36,184,485
Balance at Mar. 31, 2024	135,314			$ 4			423,196			(287,886)
Balance (in shares) at Mar. 31, 2024				35,933,586
Issuance of restricted stock (in shares)				16,833
Exercise of stock options	333						333
Exercise of stock options, (in shares)				72,795
Purchases under employee stock purchase plan	737						737
Purchases under employee stock purchase plan (in shares)				161,271
Stock-based compensation expense	4,840						4,840
Net Income (Loss)	(37,276)									(37,276)
Balance at Jun. 30, 2024	103,948			$ 4			429,106			(325,162)
Balance (in shares) at Jun. 30, 2024				36,184,485
Balance at Dec. 31, 2024	51,573			$ 4			438,820			(387,251)
Balance (in shares) at Dec. 31, 2024				36,310,713
Issuances of common stock under at the market equity offering program		$ 3,257						$ 3,257
Issuance of common stock (in shares)					1,261,537
Stock-based compensation expense	3,169						3,169
Net Income (Loss)	(29,262)									(29,262)
Balance at Mar. 31, 2025	28,737			$ 4			445,246			(416,513)
Balance (in shares) at Mar. 31, 2025				37,572,250
Balance at Dec. 31, 2024	51,573			$ 4			438,820			(387,251)
Balance (in shares) at Dec. 31, 2024				36,310,713
Net Income (Loss)	(50,002)
Balance at Jun. 30, 2025	27,510			$ 6			464,757			(437,253)
Balance (in shares) at Jun. 30, 2025				58,127,256
Balance at Mar. 31, 2025	28,737			$ 4			445,246			(416,513)
Balance (in shares) at Mar. 31, 2025				37,572,250
Purchases under employee stock purchase plan	117						117
Purchases under employee stock purchase plan (in shares)				95,421
Issuances of common stock under at the market equity offering program		$ 1,651						$ 1,651
Issuance of common stock (in shares)					1,009,585
Issuance of common stock and pre-funded warrants under the public offering			$ 15,172			$ 2			$ 15,170
Issuance of common stock and pre-funded warrants under the public offering (in shares)						19,450,000
Stock-based compensation expense	2,573						2,573
Net Income (Loss)	(20,740)									(20,740)
Balance at Jun. 30, 2025	$ 27,510			$ 6			$ 464,757			$ (437,253)
Balance (in shares) at Jun. 30, 2025				58,127,256